US Stock MarketDetailed Quotes

CRNX Crinetics

Watchlist
  • 56.060
  • -0.970-1.70%
Close Nov 22 16:00 ET
  • 56.060
  • 0.0000.00%
Post 20:02 ET
5.20BMarket Cap-15151P/E (TTM)

Crinetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Crinetics Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
239.90K
0
-239.90K
Miss Est.
-30.66%
-100.00%
-100.00%
EPS
-0.91
-0.96
-0.05
Miss Est.
+9.78%
+4.95%
-5.37%
Analyst Rating
Strong Buy

Nov 14, 2024

Crinetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.500K--
--2024/Q4-- / 700.000K--
Nov 12, 20242024/Q30.000 / 239.900K--
Aug 8, 20242024/Q2399.000K / 467.270K--
May 9, 20242024/Q1640.000K / 181.820K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.500K--
--2024/Q4-- / 700.000K--
Nov 12, 20242024/Q30.000 / 239.900K--
Aug 8, 20242024/Q2399.000K / 467.270K--
May 9, 20242024/Q1640.000K / 181.820K--

Unlock Free Earnings Estimates

Crinetics Earnings Reports

  • Crinetics | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:21 ET

  • Crinetics | 8-K: Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 12 16:14 ET

  • Crinetics | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:48 ET

  • Crinetics | 8-K: Crinetics Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 8 16:16 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 14, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data